Related references
Note: Only part of the references are listed.Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV)
Tanja Holzhey et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Heavy plus light chain monitoring correlates with clinical outcome in multiple myeloma patients
M. Michallet et al.
LEUKEMIA (2018)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar et al.
LANCET ONCOLOGY (2016)
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy
M. Alhaj Moustafa et al.
LEUKEMIA (2015)
Evaluation of the serum free light chain (sFLC) analysis in prediction of response in symptomatic multiple myeloma patients: rapid profound reduction in involved FLC predicts achievement of VGPR
Charlotte T. Hansen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Serial measurement of free light chain detects poor response to therapy early in three patients with multiple myeloma who have measurable M-proteins
Shin-ichi Fuchida et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin κ/λ Ratios
Arthur R. Bradwell et al.
CLINICAL CHEMISTRY (2009)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A. Dispenzieri et al.
LEUKEMIA (2009)
Appraisal of immunoglobulin free light chain as a marker of response
Angela Dispenzieri et al.
BLOOD (2008)
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system
C. L. H. Snozek et al.
LEUKEMIA (2008)
International uniform response criteria for multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2006)
The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chains
G Pratt et al.
LEUKEMIA & LYMPHOMA (2006)
Serum free light chains for monitoring multiple myeloma
GP Mead et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Review of 1027 patients with newly diagnosed multiple myeloma
RA Kyle et al.
MAYO CLINIC PROCEEDINGS (2003)
Share Paper
